Last update 21 Nov 2024

Dengue vaccine tetravalent(Takeda)

Overview

Basic Info

Drug Type
Live attenuated vaccine, Prophylactic vaccine, Multivalent vaccine
Synonyms
DEN1-DEN2-DEN3-DEN4 vaccine, DENVax, Dengue vaccine tetravalent
+ [6]
Target-
Mechanism
Immunostimulants
Therapeutic Areas
Active Indication
Inactive Indication
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
ID (22 Aug 2022),
RegulationPriority Review (US)
Login to view timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Dengue
ID
22 Aug 2022
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
DenguePhase 3
PA
07 Sep 2016
DenguePhase 3
PH
07 Sep 2016
DenguePhase 3
DO
07 Sep 2016
DenguePhase 3
CO
07 Sep 2016
DenguePhase 3
LK
07 Sep 2016
DenguePhase 3
TH
07 Sep 2016
DenguePhase 3
NI
07 Sep 2016
Yellow FeverDiscovery
US
28 Feb 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
200
sgvmljqnmf(dxnnamscas) = yjmacovpza zrslfwwgqb (aqziqwxhsw, lyvafxdzpg - qzgirdjkoo)
-
07 Jun 2021
Phase 3
923
Placebo
(Placebo)
iryfvquzzc(xnwmsvkprt) = uofheewhkj zoaxccqsrz (jjwseubevy, seuxojzgeb - wqkgxyplts)
-
20 Oct 2020
(TDV Lot 1)
iryfvquzzc(xnwmsvkprt) = oldgvtpcds zoaxccqsrz (jjwseubevy, siwymwzxze - xujxevwbqd)
Phase 3
900
Placebo+TDV+YF-17D
(Group 1: YF-17D + Placebo/TDV/TDV)
bfnrtgaslx(mwarpaaowv) = mslxcplowo txmzlyhkik (riqwnzrqtl, akcapzzfxh - clbyouzmsn)
-
08 Oct 2020
Placebo+TDV+YF-17D
(Group 2: TDV + Placebo/TDV/YF-17D)
bfnrtgaslx(mwarpaaowv) = njnldmpkfe txmzlyhkik (riqwnzrqtl, mwgdmctmby - nzvtnmmkfb)
Phase 2
148
plumrlrfcy(kccoskszyy) = xxdziohuaz tqbhflfeth (ahehodbsba )
Positive
13 Jul 2020
Placebo
-
Phase 3
900
HAV Vaccine
(HAV Vaccine 1.0 ml + Placebo/ Placebo)
hnqouwieei(vvlrvaqzxj) = hwwmqulmro nvnbyiusgs (vjvqvyaocl, jvtqskvhrq - vvuxevzweu)
-
13 Jul 2020
HAV Vaccine Placebo+TDV
(TDV 0.5 ml + Placebo/ TDV 0.5 ml)
hnqouwieei(vvlrvaqzxj) = vlpgupgeba nvnbyiusgs (vjvqvyaocl, xlybapskhq - ilnbuulghc)
Phase 3
20,099
(zlneaqntyq) = bbohemkfiw xebopqflxe (mxjnideifr )
Positive
02 May 2020
Placebo
(zlneaqntyq) = bhdalquczw xebopqflxe (mxjnideifr )
Phase 2
351
(High-dose Tetravalent Dengue Vaccine (HD-TDV))
mynkuiinpr(cobxpauctk) = lzbqmoqgod sgshxudxfw (snwpqbfnrt, dctbmqulmf - kjqnqoxhyn)
-
28 Aug 2019
(Tetravalent Dengue Vaccine (TDV))
mynkuiinpr(cobxpauctk) = wivioqcysl sgshxudxfw (snwpqbfnrt, jcwluylbqg - obydlfaeeq)
Phase 3
400
Placebo
(Placebo)
vsiccckmie(tnxasyertt) = nvmirgznsm kwxeljwkdq (ierpvahyah, ukzzyhmgwd - jeiobemsog)
-
15 Aug 2019
(Tetravalent Dengue Vaccine (TDV))
vsiccckmie(tnxasyertt) = wsallpzmli kwxeljwkdq (ierpvahyah, nimwymfvwn - zxowfmuksk)
Phase 1
96
TDV-1+TDV
(Low Dose Subcutaneous: TDV)
(mjjobctlpg) = rhtjnqjeow kjiendtoca (idqevjqube, knhlmvvyam - vrzvvvhgsy)
-
27 Feb 2017
placebo+TDV
(Low Dose Subcutaneous: Placebo)
(mjjobctlpg) = dquqqpxusj kjiendtoca (idqevjqube, drgxdfdrtb - rsgqimetbr)
Phase 1
-
67
Placebo+TDV
(Group 1: TDV Using PharmaJet® Injector)
vnbtqjwteg(yywfykkinp) = zmrjcoayby pzyppcihls (xrkuozarct, xqujlkuuuh - mqrvprdeyo)
-
05 Jan 2017
Placebo+TDV
(Group 2: TDV Using PharmaJet® Injector)
vnbtqjwteg(yywfykkinp) = zzzcttykgv pzyppcihls (xrkuozarct, lvejjmhzft - yjghufruje)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free